These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20512076)

  • 1. Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice.
    Jacoby JJ; Erez B; Korshunova MV; Williams RR; Furutani K; Takahashi O; Kirkpatrick L; Lippman SM; Powis G; O'Reilly MS; Herbst RS
    J Thorac Oncol; 2010 Jul; 5(7):940-9. PubMed ID: 20512076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
    Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
    Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice.
    Wu W; O'Reilly MS; Langley RR; Tsan RZ; Baker CH; Bekele N; Tang XM; Onn A; Fidler IJ; Herbst RS
    Mol Cancer Ther; 2007 Oct; 6(10):2652-63. PubMed ID: 17913856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects.
    Schwartz DL; Powis G; Thitai-Kumar A; He Y; Bankson J; Williams R; Lemos R; Oh J; Volgin A; Soghomonyan S; Nishii R; Alauddin M; Mukhopadhay U; Peng Z; Bornmann W; Gelovani J
    Mol Cancer Ther; 2009 Apr; 8(4):947-58. PubMed ID: 19372568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer.
    Schwartz DL; Bankson JA; Lemos R; Lai SY; Thittai AK; He Y; Hostetter G; Demeure MJ; Von Hoff DD; Powis G
    Mol Cancer Ther; 2010 Jul; 9(7):2057-67. PubMed ID: 20587661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of novel orthotopic nude mouse models for human small-cell lung cancer.
    Isobe T; Onn A; Morgensztern D; Jacoby JJ; Wu W; Shintani T; Itasaka S; Shibuya K; Koo PJ; O'Reilly MS; Herbst RS
    J Thorac Oncol; 2013 Feb; 8(2):140-6. PubMed ID: 23328546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha.
    Welsh S; Williams R; Kirkpatrick L; Paine-Murrieta G; Powis G
    Mol Cancer Ther; 2004 Mar; 3(3):233-44. PubMed ID: 15026543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of miR-199a on rats with non-small cell lung cancer via regulating the HIF-1α/VEGF signaling pathway.
    Wang LM; Zhang LL; Wang LW; Zhu L; Ma XX
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10363-10369. PubMed ID: 31841190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
    Jafri SH; Glass J; Shi R; Zhang S; Prince M; Kleiner-Hancock H
    J Exp Clin Cancer Res; 2010 Jul; 29(1):87. PubMed ID: 20594324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.
    Wan J; Wu W
    J Exp Clin Cancer Res; 2016 Jul; 35(1):119. PubMed ID: 27456341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
    Lee GW; Go SI; Cho YJ; Jeong YY; Kim HC; Duk Lee J; Hwang YS; Ko GH; Lee JH; Kim DC; Yang JW; Oh S; Lee JS
    J Thorac Oncol; 2012 Mar; 7(3):528-34. PubMed ID: 22258474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells.
    Palayoor ST; Mitchell JB; Cerna D; Degraff W; John-Aryankalayil M; Coleman CN
    Int J Cancer; 2008 Nov; 123(10):2430-7. PubMed ID: 18729192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
    Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML
    J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha.
    Koh MY; Spivak-Kroizman T; Venturini S; Welsh S; Williams RR; Kirkpatrick DL; Powis G
    Mol Cancer Ther; 2008 Jan; 7(1):90-100. PubMed ID: 18202012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1α to drive lung adenocarcinoma metastasis.
    Jan YH; Lai TC; Yang CJ; Lin YF; Huang MS; Hsiao M
    J Hematol Oncol; 2019 Jan; 12(1):12. PubMed ID: 30696468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
    Ping W; Jiang WY; Chen WS; Sun W; Fu XN
    Asian Pac J Cancer Prev; 2013; 14(6):3613-8. PubMed ID: 23886154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1α effects on angiogenic potential in human small cell lung carcinoma.
    Wan J; Chai H; Yu Z; Ge W; Kang N; Xia W; Che Y
    J Exp Clin Cancer Res; 2011 Aug; 30(1):77. PubMed ID: 21843314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
    Yang SL; Ren QG; Wen L; Hu JL
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
    He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.